Royal Bank of Canada’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-190
| Closed | -$1K | – | 7288 |
|
|
2025
Q3 | $1K | Buy |
+190
| New | +$943 | ﹤0.01% | 6978 |
|
|
2024
Q3 | – | Sell |
-2
| Closed | – | – | 7009 |
|
|
2024
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7187 |
|
|
2024
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7160 |
|
|
2023
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 7245 |
|
|
2023
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 7211 |
|
|
2023
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 7365 |
|
|
2023
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7170 |
|
|
2022
Q4 | $0 | Buy |
+2
| New | +$44 | ﹤0.01% | 7357 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7497 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7122 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6850 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6780 |
|
Royal Bank of Canada's EVOK Position: Q4 2025 in Review
Royal Bank of Canada sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 190 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in EVOK in Q4 2022 and held it in 8 quarters. The position peaked at $1K in Q3 2025. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.
- Royal Bank of Canada reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
- Royal Bank of Canada sold 190 Evoke Pharma shares in Q4 2025, an estimated $1K.
- Royal Bank of Canada first reported a position in Evoke Pharma in Q4 2022 and held it in 8 quarters.
- Royal Bank of Canada's Evoke Pharma position peaked at $1K in Q3 2025.
- 0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.
Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.